Stay updated on Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page.

Latest updates to the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check25 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check68 days agoChange DetectedThe page has been updated to include new information about the NAMSAL trial, which evaluates the efficacy and safety of Dolutegravir-based regimens for HIV-1 infection, along with the names of key investigators and collaborators. Additionally, the version revision has changed from v2.14.4 to v2.15.0.SummaryDifference17%
- Check75 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page.